First Header Logo Second Header Logo

Connection

M Graca Almeida-Porada to Genetic Vectors

This is a "connection" page, showing publications M Graca Almeida-Porada has written about Genetic Vectors.
Connection Strength

1.599
  1. Ramamurthy RM, Atala A, Porada CD, Almeida-Porada G. Organoids and microphysiological systems: Promising models for accelerating AAV gene therapy studies. Front Immunol. 2022; 13:1011143.
    View in: PubMed
    Score: 0.819
  2. Almeida-Porada G, Waddington SN, Chan JKY, Peranteau WH, MacKenzie T, Porada CD. In Utero Gene Therapy Consensus Statement from the IFeTIS. Mol Ther. 2019 04 10; 27(4):705-707.
    View in: PubMed
    Score: 0.160
  3. Soland MA, Bego M, Colletti E, Zanjani ED, St Jeor S, Porada CD, Almeida-Porada G. Mesenchymal stem cells engineered to inhibit complement-mediated damage. PLoS One. 2013; 8(3):e60461.
    View in: PubMed
    Score: 0.106
  4. Porada CD, Sanada C, Kuo CJ, Colletti E, Mandeville W, Hasenau J, Zanjani ED, Moot R, Doering C, Spencer HT, Almeida-Porada G. Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC. Exp Hematol. 2011 Dec; 39(12):1124-1135.e4.
    View in: PubMed
    Score: 0.095
  5. Porada CD, Almeida-Porada G. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev. 2010 Sep 30; 62(12):1156-66.
    View in: PubMed
    Score: 0.089
  6. Russo-Carbolante EM, Picanço-Castro V, Alves DC, Fernandes AC, Almeida-Porada G, Tonn T, Covas DT. Integration pattern of HIV-1 based lentiviral vector carrying recombinant coagulation factor VIII in Sk-Hep and 293T cells. Biotechnol Lett. 2011 Jan; 33(1):23-31.
    View in: PubMed
    Score: 0.089
  7. Colletti E, Lindstedt S, Park PJ, Almeida-Porada G, Porada CD. Early fetal gene delivery utilizes both central and peripheral mechanisms of tolerance induction. Exp Hematol. 2008 Jul; 36(7):816-22.
    View in: PubMed
    Score: 0.075
  8. Almeida-Porada G, Porada CD, Tran N, Zanjani ED. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood. 2000 Jun 01; 95(11):3620-7.
    View in: PubMed
    Score: 0.044
  9. Tran ND, Porada CD, Zhao Y, Almeida-Porada G, Anderson WF, Zanjani ED. In utero transfer and expression of exogenous genes in sheep. Exp Hematol. 2000 Jan; 28(1):17-30.
    View in: PubMed
    Score: 0.042
  10. Ozturk F, Park PJ, Tellez J, Colletti E, Eiden MV, Almeida-Porada G, Porada CD. Expression levels of the PiT-2 receptor explain, in part, the gestational age-dependent alterations in transduction efficiency after in utero retroviral-mediated gene transfer. J Gene Med. 2012 Mar; 14(3):169-81.
    View in: PubMed
    Score: 0.025
  11. Porada CD, Park PJ, Tellez J, Ozturk F, Glimp HA, Almeida-Porada G, Zanjani ED. Male germ-line cells are at risk following direct-injection retroviral-mediated gene transfer in utero. Mol Ther. 2005 Oct; 12(4):754-62.
    View in: PubMed
    Score: 0.016
  12. Porada CD, Park PJ, Almeida-Porada G, Liu W, Ozturk F, Glimp HA, Zanjani ED. Gestational age of recipient determines pattern and level of transgene expression following in utero retroviral gene transfer. Mol Ther. 2005 Feb; 11(2):284-93.
    View in: PubMed
    Score: 0.015
  13. Porada CD, Park P, Almeida-Porada G, Zanjani ED. The sheep model of in utero gene therapy. Fetal Diagn Ther. 2004 Jan-Feb; 19(1):23-30.
    View in: PubMed
    Score: 0.014
  14. Tran ND, Porada CD, Almeida-Porada G, Glimp HA, Anderson WF, Zanjani ED. Induction of stable prenatal tolerance to beta-galactosidase by in utero gene transfer into preimmune sheep fetuses. Blood. 2001 Jun 01; 97(11):3417-23.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.